FDA approves Mounjaro™ (tirzepatide) injection for the treatment of type 2 diabetes
U.S. Food & Drug Administration
Clinical impact of 2020 American Heart Association statement on menopause and cardiovascular disease risk
CLEVELAND CLINIC JOURNAL OF MEDICINE
More Than Half of Postmenopausal Women Experience Female Pattern Hair Loss
The North American Menopause Society